lobbying_activities: 3435864
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3435864 | 805baeef-57e9-4b18-a5a4-4cf2a2023a82 | Q3 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2025 | third_quarter | CSP | Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality | Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) | 2345000 | 0 | 0 | 2025-10-16T10:28:56-04:00 |